Announcements Trials
Browse Landscape

Phase

Phase 4 3Phase 2 3Phase 3 2Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Unknown 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 3Recurrence 1Liver Neoplasms 1Hepatitis B 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Lamivudine × Clear all
NCT01894269 2013-07-23

Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication

Sun Yat-sen University

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00555334 2009-04-01

LAM-RFA

Sun Yat-sen University

Phase 4 Unknown
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00768157 2009-02-09

Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma

Sun Yat-sen University

Phase 4 Unknown
200 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡